Shin Nippon Biomedical Laboratories, Ltd. (TYO:2395)

TYO:2395 Revenue

Shin Nippon Biomedical Laboratories had revenue of 6.43B JPY in the quarter ending December 31, 2025, a decrease of -33.90%. This brings the company's revenue in the last twelve months to 31.37B, up 2.19% year-over-year. In the fiscal year ending March 31, 2025, Shin Nippon Biomedical Laboratories had annual revenue of 32.41B with 22.54% growth.

• Revenue (ttm): 31.37B
• Revenue Growth: +2.19%
• P/S Ratio: 2.29
• Revenue / Employee: 20.48M
• Employees: 1,531
• Market Cap: 71.86B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	32.41B	5.96B	22.54%
Mar 31, 2024	26.45B	1.36B	5.42%
Mar 31, 2023	25.09B	7.34B	41.37%
Mar 31, 2022	17.75B	2.64B	17.46%
Mar 31, 2021	15.11B	549.00M	3.77%